Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Prog Retin Eye Res. 2016 Sep 21;56:84–106. doi: 10.1016/j.preteyeres.2016.09.005

Fig. 3.

Fig. 3

Localization of caveolin-1 and caveolae in control and diabetic human retinae. Like the murine retina, Cav-1 immunoreactivity is detectable in retinal vasculature and Müller glia (labeled with glutamine synthetase, “GS”, in green). In the cystic, diabetic retina in the lower panels Cav-1 immunoreactivity is enhanced in Müller glia and is also present in the choroidal neovascular (CNV) lesion. (Elliott laboratory, unpublished images).